Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News St Jude Medical study shows benefits of device monitoring for stroke risk

St Jude Medical study shows benefits of device monitoring for stroke risk

18th January 2012

St Jude Medical has published new data from a recent clinical study that shows the benefits of implantable device monitoring in detecting patients at increased risk of stroke.

The company recently sponsored the Assert Cohort study, a trial which aimed to determine whether arrhythmia detection using pacemaker-based diagnostics predicts an increased risk of stroke in elderly, hypertensive patients without history of atrial fibrillation (AF).

It was found that pacemaker patients with no AF experience and device-detected arrhythmias are around 2.5 times more likely to have a stroke than non-arrhythmic patients.

Moreover, around 85 per cent of the cases of atrial arrhythmias documented in the study were identified only by the pacemaker, showing its potentially vital role in identifying patients at risk.

Dr Mark Carlson, chief medical officer and senior vice-president of research and clinical affairs for the St Jude Medical cardiac rhythm management division, said: "The publication of these findings reminds us how important it is to identify patients with an increased risk of stroke."

Last week, the firm reported its fiscal results for the fourth quarter of 2011, highlighting a year-on-year sales increase of four percent.ADNFCR-8000103-ID-801268161-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.